Market by Drug Class, Application, and Country | Forecast 2019-2028
Triton’s research on the European dermatological therapeutics market depicts that it will grow at a CAGR of 7.92% in terms of revenue during the forecast period 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries studied in this market include:
• The United Kingdom
• France
• Spain
• Italy
• Germany
• Russia
• Rest of Europe countries
A recent study by Michael J Cork establishes that there is a high
prevalence of atopic dermatitis in the United Kingdom. Around 5–10% of adults
and 11–20% of children are said to be affected by this condition. Also, 2% of
all the affected children fall under the category of severe cases.
Similarly, according to a 2018 study on the epidemiology of rosacea in
the country, the overall rate of incidence of diagnosed rosacea was 1·65 per
1000 person-years. Approximately 80% of the people aged over 30 years were
diagnosed with this skin condition. Thus, the growing prevalence of skin
diseases in the UK has accelerated the demand for dermatological therapy. This
is boosting the growth of the nation’s dermatological therapeutics market.
Furthermore, several
organizations in the UK are working to spread awareness about skin diseases in
the country. For instance, the British
Association of Dermatologists (BAD) has launched Sun Awareness, which is a
national-level campaign to educate people about skin cancer. The enhanced public
awareness, as a result of these initiatives to educate them, has proven
effective in raising the demand for dermatological therapeutics in the United
Kingdom. This increased demand spells positive growth for the UK market in the
years to come.
Almirall is a leading
pharmaceutical company focusing on skin health. Its products are used to treat
dermatological conditions like atopic dermatitis, actinic keratosis,
inflammatory skin conditions, eczema, rosacea, psoriasis, and severe acne,
among others. Some of its well-known products include Aczone, Actikerall,
Balneum Hermal F, and Betalfarus. Founded in 1943, it is headquartered in
Barcelona, Spain.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. KEY
INSIGHTS
2.2.1. ADVANCEMENTS
IN BIOLOGICS
2.2.2. ATOPIC
DERMATITIS IS ANTICIPATED TO GROW AT HIGHEST CAGR
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. IMPACT
OF COVID-19 – DERMATOLOGICAL THERAPEUTICS
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. MARKET
DRIVERS
2.7.1. INCREASING
BURDEN OF DERMATOLOGICAL DISEASES
2.8. MARKET
RESTRAINTS
2.8.1. GRAVE
SIDE-EFFECTS OF CERTAIN CLASSES OF THERAPEUTIC DRUGS
2.9. MARKET
OPPORTUNITIES
2.9.1. RISE
IN AWARENESS LEVELS OF DISEASE ORIGIN AND PROGRESSION
2.10. MARKET
CHALLENGES
2.10.1. UNAWARENESS REGARDING
DERMATOLOGICAL DIAGNOSIS
3. EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK – BY DRUG CLASS
3.1. ANTI-INFECTIVES
3.2. CORTICOSTEROIDS
3.3. ANTI-ACNE
3.4. CALCINEURIN
INHIBITORS
3.5. RETINOIDS
3.6. OTHER
DRUG CLASSES
4. EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK - BY APPLICATION
4.1. ALOPECIA
4.2. HERPES
4.3. PSORIASIS
4.4. ROSACEA
4.5. ATOPIC
DERMATITIS
4.6. ACNE
VULGARIS
4.7. OTHER
APPLICATIONS
5. EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET – REGIONAL OUTLOOK
5.1. EUROPE
5.1.1. UNITED
KINGDOM
5.1.2. GERMANY
5.1.3. FRANCE
5.1.4. SPAIN
5.1.5. ITALY
5.1.6. RUSSIA
5.1.7. REST
OF EUROPE
6. COMPETITIVE
LANDSCAPE
6.1. ABBVIE
INC
6.2. ALLERGAN
6.3. ALMIRALL
6.4. AMGEN
INC
6.5. BAUSCH
HEALTH COMPANIES INC
6.6. GALDERMA
6.7. GLAXOSMITHKLINE
PLC
6.8. JOHNSON
& JOHNSON
6.9. NOVARTIS
AG
6.10. PFIZER
INC
6.11. AGI
DERMATICS
6.12. LEO
PHARMA A/S
6.13. MERCK
& CO
7. METHODOLOGY
& SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)
TABLE 2: MARKET
ATTRACTIVENESS INDEX
TABLE 3: VENDOR
SCORECARD
TABLE 4: EUROPE DERMATOLOGICAL
THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)
TABLE 5: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)
TABLE 6: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)
FIGURE 1: PORTER’S FIVE
FORCES ANALYSIS
FIGURE 2: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-INFECTIVES, 2019-2028 (IN $
BILLION)
FIGURE 3: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY CORTICOSTEROIDS, 2019-2028 (IN $
BILLION)
FIGURE 4: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-ACNE, 2019-2028 (IN $ BILLION)
FIGURE 5: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY CALCINEURIN INHIBITORS, 2019-2028 (IN $
BILLION)
FIGURE 6: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY RETINOIDS, 2019-2028 (IN $ BILLION)
FIGURE 7: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER DRUG CLASSES, 2019-2028 (IN $
BILLION)
FIGURE 8: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY ALOPECIA, 2019-2028 (IN $ BILLION)
FIGURE 9: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY HERPES, 2019-2028 (IN $ BILLION)
FIGURE 10: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY PSORIASIS, 2019-2028 (IN $ BILLION)
FIGURE 11: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY ROSACEA, 2019-2028 (IN $ BILLION)
FIGURE 12: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY ATOPIC DERMATITIS, 2019-2028 (IN $
BILLION)
FIGURE 13: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY ACNE VULGARIS, 2019-2028 (IN $ BILLION)
FIGURE 14: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $
BILLION)
FIGURE 15: EUROPE
DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 16: UNITED
KINGDOM DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 17: GERMANY
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 18: FRANCE
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 19: SPAIN
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 20: ITALY
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 21: RUSSIA
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 22: REST OF
EUROPE DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)